Advisory board to help guide selection of novel antibody-target pairs for ADC and T cell redirection modalities Antibody-drug conjugate and T cell redirection are two classes of treatment modalities ...
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback